DeepX Diagnostics Inc.’s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer Lesions
DeepX Diagnostics Inc., the skin cancer teledermatology and diagnostics company, announced today that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration (FDA) for teledermatology screening of...

